BackgroundCheck.run
Search For

Rodger M Smith, 815818 Wyngate Dr, Bethesda, MD 20817

Related to:
Betty L Smith 82 Richard A Smith 61 Arnold M Calhoun 84

Rodger Smith Phones & Addresses

5818 Wyngate Dr, Bethesda, MD 20817    301-5301915   

3003 Terramar St #1005, Ft Lauderdale, FL 33304   

Fort Lauderdale, FL   

Stanardsville, VA   

Gretna, VA   

Work

Company: Smith, rodger l Address: 129 E Main St, Richmond National Battlefiel, VA 22835 Phones: 540-7435179 Position: President Industries: Legal Services
Get Report
Control this profile

Mentions for Rodger M Smith

Career records & work history

Lawyers & Attorneys

Rodger Smith Photo 1

Rodger Field Smith - Lawyer

Licenses:
New York - Currently registered 1994
Education:
New York University School of Law
Rodger Smith Photo 2

Rodger Leo Smith, Luray VA - Lawyer

Address:
129 East Main Street, Luray, VA 22835
540-7435179 (Office), 540-7431567 (Fax)
129 East Main Street, Luray, VA 22835
540-7435179 (Office)
Licenses:
Virginia - Authorized to practice law 1977
Education:
Virginia Polytechnic Institute and State UniversityDegree BA - Bachelor of Arts
George Mason University School of LawDegree JD - Juris Doctor - Law
Specialties:
Personal Injury - 20%
Estate Planning - 20%
Social Security - 20%
Family - 20%
Real Estate - 20%
Associations:
District of Columbia Bar - Member
Virginia State Bar - Member
Rodger Smith Photo 3

Rodger Smith - Lawyer

Office:
Morris, Nichols, Arsht & Tunnell LLP
Specialties:
Patent Infringement, Intellectual Property, Trademark Infringement, Patent Infringement, Trademark Infringement
ISLN:
909940353
Admitted:
1994
University:
University of Pennsylvania, B.S., 1990
Law School:
New York University School of Law, J.D., 1993

License Records

Rodger G Smith

Licenses:
License #: 158 - Expired
Category: Alcohol and Drug Counselor
Issued Date: Aug 12, 1992
Effective Date: Aug 12, 1992
Expiration Date: Nov 30, 1996
Type: Alcohol and Drug Counselor

Publications & IP owners

Us Patents

Prodrugs Activated By Targeted Catalytic Proteins

US Patent:
6702705, Mar 9, 2004
Filed:
Feb 22, 1995
Appl. No.:
08/392407
Inventors:
Reid von Borstel - Potomac MD
Jan M. Casadei - Bethesda MD
Balreddy Kamireddy - Rockville MD
John Kenten - Gaithersburg MD
Mark T. Martin - Germantown MD
Richard J. Massey - Rockville MD
Andrew D. Napper - Natick MA
David M. Simpson - Adelphia MD
Rodger Smith - Jefferson MD
Richard C. Titmas - Rockville MD
Richard O. Williams - Potomac MD
Assignee:
IGEN International, Inc. - Gaithersburg MD
International Classification:
C12N 900
US Classification:
4751885
Abstract:
Catalytic antibodies are disclosed. The catalytic antibodies are specific for prodrug compounds. The catalytic antibodies enhance cleavage of an active drug moiety from a prodrug residue, thereby activating the drug.

Cycling Dna/Rna Amplification Electrochemiluminescent Probe Assay

US Patent:
6890712, May 10, 2005
Filed:
Jan 10, 2000
Appl. No.:
09/480544
Inventors:
John H. Kenten - Gaithersburg MD, US
Rodger Smith - Jefferson MD, US
Assignee:
BioVeris Corporation - Gaithersburg MD
International Classification:
C12Q001/68
C12P019/34
US Classification:
435 6, 435 911, 435 912, 435 9121, 435 915, 435 9151
Abstract:
This invention relates to an improved process for detecting and quantifying a desired nucleic acid sequence. The process involves synthesizing single stranded RNA, single stranded DNA, double-stranded DNA followed by detection using an electrochemiluminescent labeled binding species.

Humanized Antibodies Against Tl1A

US Patent:
8263743, Sep 11, 2012
Filed:
Nov 13, 2008
Appl. No.:
12/270673
Inventors:
Rodger Smith - Rockville MD, US
Palanisamy Kanakaraj - Rockville MD, US
Viktor Roschke - Rockville MD, US
Craig Rosen - Rockville MD, US
Bridget A. Cooksey - Rockville MD, US
Assignee:
Teva Biopharmaceuticals USA, Inc. - Rockville MD
International Classification:
C07K 16/00
US Classification:
5303871, 4241331
Abstract:
Disclosed are humanized antibodies that bind specifically to the receptor TNF superfamily member 15 (TNFSF15), also known as TL1A. Methods of making and using the anti-TL1A antibodies are also described. The humanized antibodies may be antagonists and may used to treat or diagnose conditions associated with TL1A function.

Prodrugs Activated By Targeted Catalytic Proteins

US Patent:
2003009, May 22, 2003
Filed:
Jul 25, 2002
Appl. No.:
10/205115
Inventors:
John Kenten - Gaithersburg MD, US
Reid Von Borstel - Potomac MD, US
Jan Casadei - Bethesda MD, US
Balreddy Kamireddy - Rockville MD, US
Mark Martin - Germantown MD, US
Richard Massey - Rockville MD, US
Andrew Napper - Natick MA, US
David Simpson - Adelphi MD, US
Rodger Smith - Jefferson MD, US
Richard Titmas - Rockville MD, US
Richard Williams - Potomac MD, US
Assignee:
Igen, Inc.
International Classification:
A61K031/704
A61K031/66
C07H015/24
C07F009/02
A61K031/235
US Classification:
514/034000, 514/120000, 514/110000, 514/538000, 514/544000, 536/006100, 558/166000, 558/179000, 560/019000, 560/103000
Abstract:
Disclosed and claimed are prodrugs activated by catalytic proteins, such as enzymes and catalytic antibodies. The invention comprehends such prodrugs, as well as haptens, to elicit catalytic antibodies to activate the prodrugs. The prodrugs are useful as cytotoxic chemotherapeutic agents; e.g., as antitumor agents.

Prodrugs Activated By Targeted Catalytic Proteins

US Patent:
2005012, Jun 9, 2005
Filed:
Nov 3, 2003
Appl. No.:
10/699966
Inventors:
John Kenten - Gaithersburg MD, US
Reid Borstel - Potomac MD, US
Jan Casadei - Bethesda MD, US
Balreddy Kamireddy - Rockville MD, US
Mark Martin - Germantown MD, US
Richard Massey - Rockville MD, US
Andrew Napper - Natick MA, US
David Simpson - Adelphi MD, US
Rodger Smith - Jefferson MD, US
Richard Titmas - Rockville MD, US
Richard Williams - Potomac MD, US
International Classification:
A61K039/395
C07H015/24
C07K016/18
US Classification:
424130100, 530388100, 540200000, 536006400, 560040000, 530395000, 530403000
Abstract:
Disclosed and claimed are prodrugs activated by catalytic proteins, such as enzymes and catalytic antibodies. The invention comprehends such prodrugs, as well as haptens, to elicit catalytic antibodies to activate the prodrugs. The prodrugs are useful as cytotoxic chemotherapeutic agents; e.g., as antitumor agents.

Rapid Nucleic Acid Assay

US Patent:
2005018, Aug 18, 2005
Filed:
Mar 28, 2005
Appl. No.:
11/090061
Inventors:
John Kenten - Gaithersburg MD, US
Rodger Smith - Jefferson MD, US
Assignee:
BioVeris Corporation - Gaithersburg MD
International Classification:
C12Q001/68
C12P019/34
US Classification:
435006000, 435091200
Abstract:
This invention relates to an improved process for detecting and quantifying a desired nucleic acid sequence. The process involves synthesizing single stranded RNA, single stranded DNA, double-stranded DNA followed by detection using an electrochemiluminescent labeled binding species.

Albumin Fusion Proteins

US Patent:
2009002, Jan 29, 2009
Filed:
Jun 7, 2007
Appl. No.:
11/759843
Inventors:
Craig A. Rosen - Laytonsville MD, US
Adam Bell - Germantown MD, US
David W. LaFleur - Washington DC, US
Douglas B. Woods - Gaithersburg MD, US
Ping Feng - Germantown MD, US
Rodger G. Smith - Jefferson MD, US
Baiqin Teng - Rockville MD, US
International Classification:
A61K 38/00
C07K 14/00
C07K 1/00
C12N 15/11
C12N 15/00
C12N 5/06
A61P 43/00
US Classification:
514 12, 530362, 530402, 536 231, 4353201, 435325
Abstract:
The present invention encompasses albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins of the invention and using these nucleic acids, vectors, and/or host cells. Additionally the present invention encompasses pharmaceutical compositions comprising albumin fusion proteins and methods of treating, preventing, or ameliorating diseases, disorders or conditions using albumin fusion proteins of the invention.

Humanized Antibodies Against Tl1A

US Patent:
2012030, Dec 6, 2012
Filed:
Aug 14, 2012
Appl. No.:
13/585792
Inventors:
Rodger Smith - Rockville MD, US
Palanisamy Kanakaraj - Rockville MD, US
Viktor Roschke - Rockville MD, US
Craig Rosen - Rockville MD, US
Bridget A. Cooksey - Rockville MD, US
International Classification:
A61K 39/395
A61K 49/22
A61P 29/00
A61P 37/00
A61P 35/00
A61P 1/00
A61P 11/00
A61P 19/02
A61P 25/00
A61P 37/06
A61P 17/06
A61P 9/10
A61P 35/02
A61P 37/02
A61K 51/10
US Classification:
424 149, 4241331, 4241351, 4241301, 4241341, 4241781, 424 95
Abstract:
Disclosed are humanized antibodies that bind specifically to TNF superfamily member 15 (TNFSF15), also known as TL1A. Methods of making and using the anti-TL1A antibodies are also described. The humanized antibodies may be antagonists and may used to treat or diagnose conditions associated with TL1A function.

Isbn (Books And Publications)

Vampires

Author:
Rodger Smith
ISBN #:
0001374303

This Old Man

Author:
Rodger Smith
ISBN #:
0001845594

Abc Dinosaurs

Author:
Rodger Smith
ISBN #:
0434963720

Harry Potter And The Sorcerers Stone

Author:
Rodger Smith
ISBN #:
0439294827

The Magic Toyshop

Author:
Rodger Smith
ISBN #:
0671669079

In And Out

Author:
Rodger Smith
ISBN #:
0671866303

Daniel And The Lions

Author:
Rodger Smith
ISBN #:
0679877452

An Investigation Into The Extent Of The Desegregation Of Bus Services In Southern Africa In 1986

Author:
Rodger Smith
ISBN #:
0798844078

Possible Relatives

Cynthia Smith  David Y Smith  A Smith  Cyril E Smith  Cyrus R Smith  D J Smith  Davida W Smith  Rodger Johnson  Rodger R White  Rodger L Jones 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.